The current price is in 3,29$, In this post we are going to talk about the listed company Aquestive Therapeutics Inc, its leaders are A. Ernest Toth (Chief Financial Officer & Senior Vice President), A. Mark Schobel (Chief Technology & Innovation Officer), Daniel Barber (Chief Operating Officer & Senior Vice President), Keith J. Kendall (President, Chief Executive Officer & Director), Peter Boyd (SVP-Business Process & Information Technology), they lead it to work in Biotechnology: Pharmaceutical Preparations especially in the North America region.
Today this action begins with yesterday's closing price, desconocido$.
The current range on the same day is from 3,00$ - 3,42$, with a percentage difference of 3,21$ quite wide that helps to be able to do day trading.
He earns an annual income of desconocido.
The last registered opening is of desconocido.
To detect if it is a good time to enter or exit a stock, many traders use the lowest and highest values of the last 52 weeks. In this action, prices have moved between 0,00$ and 0,00$.
The EPS, or net profit divided by the number of shares in progress, tells us with a high value that we must enter and with a low value that we must leave, it is a result of how the company has done in the last year.
Buscar
